SPYRE THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
SPYRE THERAPEUTICS, INC. (SYRE) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.45 million as of 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2023-03-02
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.45M.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.96M.
- 2020-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.52M.
- 2019-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.07M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2022-12-31 | $1.45M 10-K · filed 2023-03-02 |
| 2021-12-31 | $1.96M 10-K · filed 2022-03-08 |
| 2020-12-31 | $2.52M 10-K · filed 2021-03-18 |
| 2019-12-31 | $3.07M 10-K · filed 2020-02-24 |
| 2019-09-30 | $3.23M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $3.39M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $68.00K 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |